Fanhua (FANH) said Friday its subsidiary Fanhua BluePlus Health Management is partnering with Shanghai Biotecan Pharmaceuticals to provide new health management services.
The companies will collaborate on areas including medical testing, health management and cell therapy, Fanhua said.
Finance details of the partnership were not disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.